Ghrp-2 — reference
Synthetic ghrelin-receptor agonist used to stimulate GH release.
Regulatory status
Not FDA-Approved. Not approved for human use. Sold as a research chemical. Banned by WADA.
Reported cautions
Pharmacokinetics
Published figures give an elimination half-life of ~15–30 minutes. Short-acting GH secretagogue; human PK data is limited but consistent across small studies.
This figure is tagged PK study in our evidence system. This figure comes from a published pharmacokinetic study rather than a label or registration trial. Sample sizes in such studies are often small and figures vary between them, so treat the number as a range rather than a constant. You can see the shape this implies between doses in the Half-Life Visualizer, and compare it against every other compound in the Half-Life Data Table. Our sourcing page explains what each tier means.
Remember that an estimated curve is a model built from a population figure, not a measurement of your blood. Individual clearance varies, and for depot injections the figure describes release from the injection site rather than the compound clearing. Half-life explained →
What Peptide Plug does and does not publish
This page carries regulatory status, general context and published pharmacokinetics. It carries no dose, frequency or cycle information — that is a deliberate editorial line, because dosing is a clinical decision rather than reference data. We also do not sell, supply, source or link to vendors for any compound.
Frequently asked
Is Ghrp-2 FDA-approved?
What is the half-life of Ghrp-2?
How reliable is that half-life figure?
What cautions are associated with Ghrp-2?
Does Peptide Plug publish dosing for Ghrp-2?
Does Peptide Plug sell Ghrp-2?
Related tools
Free, no account required.